Is Phosphatidylserine Safe?

Chemical Structure and Metabolism of Phosphatidylserine

Phosphatidylserine (PS) is an acidic phospholipid found in cell membranes. Its chemical structure consists of a glycerol backbone, two fatty acid chains, a phosphate group, and an L-serine residue. Commercial phosphatidylserine powder is commonly derived from soybean lecithin through enzymatic conversion, typically using phospholipase D.

After oral ingestion, phosphatidylserine supplements undergo digestion in the gastrointestinal tract. Pancreatic enzymes break down phospholipids into smaller components, including fatty acids and lysophospholipids, which can be absorbed by intestinal cells. These components may then be used to synthesize phospholipids or contribute to the body's overall phospholipid pool.

The human body can also synthesize phosphatidylserine through enzymatic reactions involving other phospholipids and serine. Understanding phosphatidylserine metabolism helps ingredient manufacturers and supplement formulators evaluate its composition, processing requirements, and potential applications in dietary supplement formulations.

Regulatory Recognition and Safety Status of Phosphatidylserine

The safety and regulatory status of phosphatidylserine depend on the ingredient source, intended use, dosage, and destination market.

U.S. Food and Drug Administration (FDA):

Certain phosphatidylserine ingredients may qualify for Generally Recognized as Safe (GRAS) status under applicable conditions. However, GRAS status is not a blanket approval for all PS products. The FDA also distinguishes qualified health claims from formally authorized health claims, so manufacturers should verify the applicable claim language before marketing products.

European Union (EU):

Certain forms of phosphatidylserine PS, including PS derived from soy and fish phospholipids, have specific novel food authorizations. These authorizations establish permitted food categories, maximum use levels, and labeling requirements. Manufacturers should check the applicable conditions before using bulk phosphatidylserine as a food ingredient or dietary supplement ingredient.

China:

Phosphatidylserine was approved as a new resource food under Ministry of Health Announcement No. 15 of 2010, subject to specified conditions of use and quality requirements.

Toxicological Assessment and Preclinical Safety Studies of Phosphatidylserine

Phosphatidylserine (PS) is a phospholipid used in dietary supplements and functional nutrition products. Evaluating phosphatidylserine safety is important for ingredient manufacturers, formulators, and quality assurance teams. Preclinical safety assessments may include acute oral toxicity, genotoxicity, and subchronic toxicity studies to characterize potential risks associated with phosphatidylserine powder. However, study conclusions should be supported by specific test reports for the relevant raw material.

Acute Oral Toxicity Studies

Acute toxicity studies evaluate the short-term effects of a single oral dose of phosphatidylserine in experimental animals, such as rats or mice. These studies may assess mortality, clinical signs, and pathological changes to estimate acute toxicity, including the median lethal dose (LD50) when appropriate. An oral LD50 above 5,000 mg/kg body weight, if established by the study, generally indicates low acute toxicity under the tested conditions. Results should be interpreted according to the tested formulation, dose, and study protocol.

Phosphatidylserine Genotoxicity Testing

Phosphatidylserine genotoxicity testing evaluates whether the ingredient may cause gene mutations or chromosomal damage. Standard preclinical assessments may include:

• Ames test: Evaluates bacterial reverse mutations, with and without metabolic activation.

In vitro chromosomal aberration test: Examines potential chromosomal damage in cultured mammalian cells.

In vivo micronucleus test: Assesses micronucleus formation in relevant animal cells.

Negative results across appropriate assays can support the conclusion that the tested phosphatidylserine material showed no evidence of genotoxicity under the study conditions.

Subchronic Toxicity and NOAEL

A 90-day subchronic oral toxicity study evaluates repeated exposure to phosphatidylserine in laboratory animals. Researchers may monitor body weight, food consumption, hematology, serum biochemistry, organ weights, and tissue pathology. The phosphatidylserine NOAEL is the highest tested dose at which no adverse effects attributable to the substance are identified under the study conditions.

Who Should Use Phosphatidylserine Carefully?

When evaluating phosphatidylserine supplement safety, manufacturers and formulators should consider population-specific evidence, dosage levels, potential interactions, and raw material purity.

Phosphatidylserine Benefits and Safety for the Elderly

Older adults are an important population in phosphatidylserine clinical studies. In one trial involving 157 older adults without dementia, PS combined with docosahexaenoic acid (DHA) was administered at 300 mg/day for 15 weeks without reported adverse effects. A subsequent open-label phase using 100 mg/day for 30 weeks was also well tolerated.

In another six-month study involving older adults with mild memory impairment, soy-derived phosphatidylserine was evaluated at daily doses of 100 mg and 300 mg. Neither dose was associated with abnormal changes in blood markers or vital signs. These findings provide preliminary evidence of short- to medium-term tolerability in older adults, although they do not establish long-term safety for every population.

Phosphatidylserine for Children and Adolescents

Evidence regarding phosphatidylserine for children remains limited. A randomized controlled trial in healthy children aged 8–12 years evaluated sunflower-derived phosphatidylserine for cognitive outcomes. Safety monitoring identified no significant adverse events attributed to the supplement during the study.

However, a case report described irritability, agitation, and suicidal ideation in a seven-year-old child with attention-deficit/hyperactivity disorder (ADHD) who received methylphenidate alongside phosphatidylserine (100 mg/day) and citicoline. Symptoms recurred after the regimen was resumed and resolved after the supplements were discontinued. A single case cannot establish causality, but it highlights the importance of medical supervision and monitoring for potential adverse effects, particularly when supplements are combined with prescription medications.

Phosphatidylserine Dosage and Purity Considerations

Health Canada's 300 mg/day maximum recommended intake provides a regulatory reference for evaluating phosphatidylserine dosage. Formulators should verify applicable requirements in their target markets rather than treating this level as a universal recommendation.

Phosphatidylserine purity is another important quality consideration. An in vitro study using cortical neurons derived from human embryonic stem cells found that an 80%-purity PS preparation activated the SIRT1–PGC-1α pathway more effectively than a 50%-purity preparation. However, laboratory findings do not establish superior clinical outcomes or safety in humans.

The Impact of Raw Material Sources and Quality Control on Phosphatidylserine Safety

The safety of phosphatidylserine (PS) powder depends on both the properties of the ingredient and the quality control measures used during manufacturing. Historically, PS phosphatidylserine was extracted from bovine brain tissue. Today, commercial phosphatidylserine raw materials are commonly produced from soybean or sunflower lecithin through enzymatic conversion, helping reduce concerns associated with animal-derived materials. A reliable phosphatidylserine manufacturer should implement strict quality control procedures throughout production.

Key Quality Control Measures

• Raw Material Purification:

Control residual proteins, allergens, and other impurities. For soy-derived PS, phosphatidylserine manufacturers should assess allergen risks and verify relevant specifications.

• Heavy Metal and Microbial Testing:

Test phosphatidylserine powder for lead, arsenic, cadmium, mercury, and microbial contaminants, including Salmonella and E. coli, according to applicable standards.

• Residual Solvent Control:

Monitor solvents such as ethanol and n-hexane, where used, to ensure compliance with applicable food-grade phosphatidylserine or pharmaceutical requirements.

Comparison of Product Characteristics and Application Safety of Phosphatidylserine in Different Dosage Forms

FAQs:

Q1. Is phosphatidylserine safe to take as a dietary supplement?

A: Phosphatidylserine PS is a phospholipid naturally present in cell membranes and is available as a dietary supplement ingredient. Its safety depends on the source, dose, product quality, and individual health factors. Manufacturers should evaluate available safety data, establish appropriate usage levels, and verify compliance with the regulations of the target market before developing phosphatidylserine PS supplements.

Q2. What is a typical daily dosage of phosphatidylserine?

A: Phosphatidylserine supplements are commonly formulated to provide approximately 100–300 mg per day for adults, although appropriate amounts depend on the intended use and supporting evidence. This range should not be interpreted as a universal safety limit or a recommended dose for every individual. Supplement manufacturers should review relevant clinical studies, applicable regulations, and product-specific safety data when establishing serving sizes.

Q3. What are the possible side effects of phosphatidylserine?

A: Phosphatidylserine is generally well tolerated in studies using commonly investigated supplemental amounts, but some people may experience mild gastrointestinal symptoms, including stomach discomfort or digestive upset. Reported tolerability can vary by formulation, dose, and individual sensitivity. Manufacturers should avoid guaranteeing that PS products are free from side effects and should provide appropriate safety information on finished-product labels.

Q4. Is soy-derived phosphatidylserine safe?

A: Soy-derived phosphatidylserine is used in dietary supplement formulations, but its suitability depends on manufacturing quality, residual protein levels, and the consumer's individual sensitivities. People with soy allergies should consult a qualified healthcare professional before using soy-derived products. Manufacturers should verify allergen-control procedures and provide accurate allergen declarations based on the product's composition and applicable labeling requirements.

Q5. Is sunflower-derived phosphatidylserine safer than soy-derived phosphatidylserine?

A: Sunflower-derived phosphatidylserine may be suitable for formulations targeting consumers who avoid soy ingredients. However, sunflower-derived PS is not automatically safer or more effective than soy-derived PS. Both sources require appropriate identity testing, purity assessment, contaminant control, and manufacturing quality assurance. Formulators should select a source based on allergen requirements, product specifications, consumer needs, and regulatory considerations.

Q6. Can phosphatidylserine be taken with other dietary supplements?

A: Pure phosphatidylserine may be included in multi-ingredient formulations alongside vitamins, minerals, and other nutritional ingredients. However, compatibility during manufacturing and potential interactions during use are separate considerations. Formulators should assess ingredient stability, dosage, and available safety evidence. Consumers taking prescription medications or multiple supplements should consult a qualified healthcare professional before combining products.

Q7. Is phosphatidylserine safe for long-term use?

A: Available clinical studies provide some information about phosphatidylserine use over limited periods, but evidence may be insufficient to establish the safety of every dose, source, or phosphatidylserine formulation over many years. Long-term safety should not be assumed solely from short-term tolerability. Manufacturers should review the duration and quality of available studies and avoid unsupported claims about lifelong safety.

Q8. Is phosphatidylserine safe during pregnancy and breastfeeding?

A: There is insufficient evidence to establish the safety of supplemental phosphatidylserine during pregnancy and breastfeeding. People who are pregnant, planning pregnancy, or breastfeeding should consult a qualified healthcare professional before using PS supplements. Manufacturers should consider the limitations of the available evidence when determining whether products are appropriate for these populations and when preparing consumer safety information.

Conclusion:

Phosphatidylserine PS is widely studied for its safety as a dietary supplement ingredient. Research indicates that phosphatidylserine safety depends on dosage, source, product quality, and intended use. Toxicological and clinical studies have evaluated its potential effects, including studies using daily intakes of 300 mg in adults. However, safety findings should be interpreted according to the specific PS source and study conditions. Manufacturers should also consider applicable regulatory requirements in their target markets.

As a professional bulk phosphatidylserine supplier, Guanjie Biotech offers plant-derived phosphatidylserine powder and other product forms sourced from soybeans and sunflowers. Our portfolio includes powders, liquids, water-soluble powders, and granules for different formulation needs. We emphasize controlled production, raw material traceability, and quality testing to support consistent phosphatidylserine raw material supply. We also provide phosphatidylserine OEM and ODM services for B2B customers. For bulk inquiries, specifications, or technical documentation, contact info@gybiotech.com.

References:

[1] Jorissen, B. L., Brouns, F., Van Boxtel, M. P., & Riedel, W. J. (2002). Safety of soy-derived phosphatidylserine in elderly people. Nutritional Neuroscience, *5*(5), 337-343.

[2] Vakhapova, V., Richter, Y., Cohen, T., Herzog, Y., & Korczyn, A. D. (2011). Safety of phosphatidylserine containing omega-3 fatty acids in non-demented elderly: a double-blind placebo-controlled trial followed by an open-label extension. BMC Neurology, *11*, 79.

[3] Lifshitz, Y., Levi, L., Eyal, I., Cohen, T., & Tessler, S. (2015). Sub-chronic (13-week) oral toxicity study, preceded by an in utero exposure phase and genotoxicity studies with fish source phosphatidylserine in rats. Food and Chemical Toxicology, *86*, 234-244.

[4] Subaşı Turgut, F. (2025). Recurrent Suicidality Following Rechallenge with Phosphatidylserine and Citicoline in a Pediatric ADHD Patient Treated with Methylphenidate: A Cautionary Case Report. Psychiatry and Clinical Psychopharmacology, *36*(2), 211-215.

[5] Jeon, S. M., Cho, S., Lee, Y. S., Lee, J. Y., Kang, E. J., Kim, T. D., Shin, J., Jo, H., & Kang, S. U. (2026). Higher Purity of Phosphatidylserine Improves Human Cortical Neuron Function by Modulating SIRT1-PGC-1α Pathways. Brain Sciences, *16*(2), Article 194.

[6] Friling, M., Jackson, P. A., Kennedy, D., Dodd, F., & Smith, E. (2025). The cognitive effects of supplementation with sunflower phosphatidyl serine in healthy children aged 8 to 12 years: a randomized controlled trial. Nutrition Journal.

[7] Expert Panel GRAS Determination. Generally Recognized As Safe (GRAS) Determination for the Addition of Phosphatidylserine from Marine Source (DHAPS™) to Foods. U.S. Food and Drug Administration.

[8] Health Canada. (2024). Modification to the List of permitted supplemental ingredients to enable the use of phosphatidylserine (soy).